Serum Institute Seeks Indemnity, Says “Same Rules For All”: Sources

After Pfizer and Moderna, Covishield-maker Serum Institute of India (SII) has asked for indemnity from liability, according to sources. All vaccine makers, whether Indian or foreign, should be…

Similar Articles

Comments

spot_img

Most Popular

You cannot copy content of this page

In Order to Strengthen Democracy, Citizens Should Bear the Cost of Impartial Journalism. Join 1-Rupee Campaign